157 related articles for article (PubMed ID: 38418494)
1. Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach.
Guo J; Fathi Kazerooni A; Toorens E; Akbari H; Yu F; Sako C; Mamourian E; Shinohara RT; Koumenis C; Bagley SJ; Morrissette JJD; Binder ZA; Brem S; Mohan S; Lustig RA; O'Rourke DM; Ganguly T; Bakas S; Nasrallah MP; Davatzikos C
Sci Rep; 2024 Feb; 14(1):4922. PubMed ID: 38418494
[TBL] [Abstract][Full Text] [Related]
2. Multi-parametric and multi-regional histogram analysis of MRI: modality integration reveals imaging phenotypes of glioblastoma.
Li C; Wang S; Serra A; Torheim T; Yan JL; Boonzaier NR; Huang Y; Matys T; McLean MA; Markowetz F; Price SJ
Eur Radiol; 2019 Sep; 29(9):4718-4729. PubMed ID: 30707277
[TBL] [Abstract][Full Text] [Related]
3. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.
Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R
Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370
[TBL] [Abstract][Full Text] [Related]
4. Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1.
Rathore S; Akbari H; Rozycki M; Abdullah KG; Nasrallah MP; Binder ZA; Davuluri RV; Lustig RA; Dahmane N; Bilello M; O'Rourke DM; Davatzikos C
Sci Rep; 2018 Mar; 8(1):5087. PubMed ID: 29572492
[TBL] [Abstract][Full Text] [Related]
5. Biological underpinnings of radiomic magnetic resonance imaging phenotypes for risk stratification in IDH wild-type glioblastoma.
Guan F; Wang Z; Qiu Y; Guo Y; Pei D; Wang M; Xing A; Liu Z; Yu B; Cheng J; Liu X; Ji Y; Yan D; Yan J; Zhang Z
J Transl Med; 2023 Nov; 21(1):841. PubMed ID: 37993907
[TBL] [Abstract][Full Text] [Related]
6. Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma.
Fathi Kazerooni A; Saxena S; Toorens E; Tu D; Bashyam V; Akbari H; Mamourian E; Sako C; Koumenis C; Verginadis I; Verma R; Shinohara RT; Desai AS; Lustig RA; Brem S; Mohan S; Bagley SJ; Ganguly T; O'Rourke DM; Bakas S; Nasrallah MP; Davatzikos C
Sci Rep; 2022 May; 12(1):8784. PubMed ID: 35610333
[TBL] [Abstract][Full Text] [Related]
7. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
[TBL] [Abstract][Full Text] [Related]
8. Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.
Kickingereder P; Neuberger U; Bonekamp D; Piechotta PL; Götz M; Wick A; Sill M; Kratz A; Shinohara RT; Jones DTW; Radbruch A; Muschelli J; Unterberg A; Debus J; Schlemmer HP; Herold-Mende C; Pfister S; von Deimling A; Wick W; Capper D; Maier-Hein KH; Bendszus M
Neuro Oncol; 2018 May; 20(6):848-857. PubMed ID: 29036412
[TBL] [Abstract][Full Text] [Related]
9. Radiogenomics correlation between MR imaging features and major genetic profiles in glioblastoma.
Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
Eur Radiol; 2018 Oct; 28(10):4350-4361. PubMed ID: 29721688
[TBL] [Abstract][Full Text] [Related]
10. Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.
Prasanna P; Patel J; Partovi S; Madabhushi A; Tiwari P
Eur Radiol; 2017 Oct; 27(10):4188-4197. PubMed ID: 27778090
[TBL] [Abstract][Full Text] [Related]
11. Diffusion tensor imaging-based machine learning for IDH wild-type glioblastoma stratification to reveal the biological underpinning of radiomic features.
Wang Z; Guan F; Duan W; Guo Y; Pei D; Qiu Y; Wang M; Xing A; Liu Z; Yu B; Zheng H; Liu X; Yan D; Ji Y; Cheng J; Yan J; Zhang Z
CNS Neurosci Ther; 2023 Nov; 29(11):3339-3350. PubMed ID: 37222229
[TBL] [Abstract][Full Text] [Related]
12. Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.
Li Y; Liang Y; Sun Z; Xu K; Fan X; Li S; Zhang Z; Jiang T; Liu X; Wang Y
Neuroradiology; 2019 Nov; 61(11):1229-1237. PubMed ID: 31218383
[TBL] [Abstract][Full Text] [Related]
13. Imaging Genomics in Glioblastoma Multiforme: A Predictive Tool for Patients Prognosis, Survival, and Outcome.
Anil R; Colen RR
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):731-740. PubMed ID: 27742113
[TBL] [Abstract][Full Text] [Related]
14. Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review.
Fathi Kazerooni A; Bakas S; Saligheh Rad H; Davatzikos C
J Magn Reson Imaging; 2020 Jul; 52(1):54-69. PubMed ID: 31456318
[TBL] [Abstract][Full Text] [Related]
15. Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma.
Beig N; Bera K; Prasanna P; Antunes J; Correa R; Singh S; Saeed Bamashmos A; Ismail M; Braman N; Verma R; Hill VB; Statsevych V; Ahluwalia MS; Varadan V; Madabhushi A; Tiwari P
Clin Cancer Res; 2020 Apr; 26(8):1866-1876. PubMed ID: 32079590
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrocyte Transcription Factor 2 as a Potential Prognostic Biomarker of Glioblastoma: Kaplan-Meier Analysis and the Development of a Binary Predictive Model Based on Visually Accessible Rembrandt Image and Magnetic Resonance Imaging Radiomic Features.
Mei N; Lu Y; Yang S; Jiang S; Ruan Z; Wang D; Liu X; Ying Y; Li X; Yin B
J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):650-658. PubMed ID: 37380154
[TBL] [Abstract][Full Text] [Related]
17. Cluster Analysis of DSC MRI, Dynamic Contrast-Enhanced MRI, and DWI Parameters Associated with Prognosis in Patients with Glioblastoma after Removal of the Contrast-Enhancing Component: A Preliminary Study.
Chung H; Seo H; Choi SH; Park CK; Kim TM; Park SH; Won JK; Lee JH; Lee ST; Lee JY; Hwang I; Kang KM; Yun TJ
AJNR Am J Neuroradiol; 2022 Nov; 43(11):1559-1566. PubMed ID: 36175084
[TBL] [Abstract][Full Text] [Related]
18. Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.
Kickingereder P; Burth S; Wick A; Götz M; Eidel O; Schlemmer HP; Maier-Hein KH; Wick W; Bendszus M; Radbruch A; Bonekamp D
Radiology; 2016 Sep; 280(3):880-9. PubMed ID: 27326665
[TBL] [Abstract][Full Text] [Related]
19. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.
Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B
Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702
[TBL] [Abstract][Full Text] [Related]
20. MRI Features May Predict Molecular Features of Glioblastoma in
Park CJ; Han K; Kim H; Ahn SS; Choi D; Park YW; Chang JH; Kim SH; Cha S; Lee SK
AJNR Am J Neuroradiol; 2021 Mar; 42(3):448-456. PubMed ID: 33509914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
